Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1995-06-05
1998-12-22
Huff, Sheela
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
435 71, 435 72, 435 79, 435 791, 435 792, 435 793, 435 794, 435 795, G01N 33543
Patent
active
058518398
ABSTRACT:
Peptides useful in inhibiting platelet aggregation are disclosed. These peptides contain the binding sequence Har-G-D and are disulfide-bridged cyclic compounds.
REFERENCES:
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4652639 (1987-03-01), Stabinsky
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4661471 (1987-04-01), Hawiger et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4992463 (1991-02-01), Troeng et al.
patent: 5023233 (1991-06-01), Nutt
patent: 5100875 (1992-03-01), de Rotrou
patent: 5318899 (1994-06-01), Scarborough et al.
patent: 5338723 (1994-08-01), Nutt
patent: 5340798 (1994-08-01), Nutt
patent: 5344783 (1994-09-01), Scarborough et al.
patent: 5374622 (1994-12-01), Nutt
Ali et al., Structure-Activity studies Toward the Improvement of Antiaggregatory Activity of Arg-Gly-Asp-Ser (RGDS) Peptides: Chemistry, Structure and Biology (Proceedings of the 11th American Peptide Symposium), Marshall, G.R. and River, J.E. Editors, ESCOM, Leiden (1990) pp. 94-96.
Bennett et al., Inhibition of Fibrinogen Binding Stimulated Human Platelets by a Monoclonal Antibody, Proc. Natl. Acad. Sci., 80:2417-2421 (1983).
Cadroy et al., RGDV Peptide Selectively Inhibits Platelet-Dependent Thrombus Formation In Vivo, J. Clin. Invest., 84:939-944 (1989).
Chao et al., Applaggin: A Potent Inhibitor of Platelet Aggregation and Secretion, Thrombosis and Haemostasis 62(1):50, Abstract No. 120 (1989).
Chao et al., Agkistrodon Piscivorus Piscivorus Platelet Aggregation Inhibitor: A Potent Inhibitor of Platelet Activation, Proc. Natl. Acad. Sci., 86:8050-8054 (1989).
Dennis et al., Platelet Glycoprotein IIb-IIIa Protein Antagonists from Snake Venoms: Evidence for a Family of Platelet-Aggregation Inhibitors, Proc. Natl. Acad. Sci., 87:2471-2475 (1989).
Gan et al., Echistatin, A Potent Platelet Aggregation Inhibitor from the Venom of the Viper, Echis Carinatus, J. Biol. Chem., 263(36):19827-19832 (1988).
Garsky et al, Chemical Synthesis of Echistatin, A Potent Inhibitor of Platelet Aggregation from Echis Carinatus: Synthesis and Biological Activity of Selected Analogs, Proc. Natl. Acad. Sci., 86:4022-4026 (1989).
Huang et al., Trigramin A Low Molecular Weight Peptide Inhibiting Fibrinogen Interaction With Platelet Receptor Expressed on Glycoprotein IIb-IIIa Complex, J. Biol. Chem., 262(33):16157-16163 (1987).
Huang et al., Trigramin: Primary Structure and Its Inhibition of von Willebrand Vactor Binding to Glycoprotein IIb/IIIa Complex on Human Platelets, Biochemistry, 28:661-666 (1989).
Huang et al., Halysin, A Potent Platelet Aggregation Inhibitor, Inhibits the Fibrinogen Binding to the Activated Platelets, Thrombosis and Haemostasis 62(1):48, Abstract No. 112 (1989).
Kloczewiak et al., Platelet Receptor Recognition Domain on the .gamma. Chain of Human Fibrinogen and Its Synthetic Peptide Analogues, Biochemistry, 28:2915-2919 (1989).
Knudsen et al., Trigramin, an RGD-Containing Peptide from Snake Venom, Inhibits Cell-Sbustratum Adhesion of Human Melanoma Cells, Exerimental Cell Research, 179:42-49 (1988).
Nachman et al., Complex Formation of Platelet Membrane Glycoproteins IIB and IIIa with Fibrinogen, Amer, Soc. for Clin. Invest., 69:263-269 (1982).
Niewiarowski et al., Potential Application of RGD Containing Peptides from Viper Venoms (Disintegrins) in Antiplatelet Therapy, Thrombosis and Haemostasis, 62(1):319, Abstract No. SY-XIV-5 (1989).
Phillips et al., The Platelet Membrane Glycoprotein IIb-IIIa Complex, Blood, 71:831-843 (1988).
Pierschbacher et al., Influence of Stereochemistry of the Sequence Arg-Asp-Xaa on Binding Specificity in Cell Adhesion, J. Biol. Chem., 262:17294-17298 (1987).
Pierschbacher and Ruoslahti, Variants of the Cell Recognition Site of Fibronectin that Retain Attachment-Promoting Activity, Proc. Natl. Acad. Sci., 81:5985-5988 (1984).
Plow et al., Arginyl-Glycyl-Aspartic Acid Sequences and Fibrinogen Binding to Platelets, Blood, 70(1):110-115 (1987).
Plow et al., The Effect of Arg-Gly-Asp-containing peptides on Fibrinogen and von Willebrand Factor Binding to Platelets, Proc. Natl. Acad. Sci., 82:8057-8061 (1985).
Niewiarowski et al., Inhibition of Platelet Adhesion to Surfaces of Extracorporeal Circuit by RGD Containing Peptides from Viper Venoms, Thrombosis and Haemostasis, 62:319, Abstract No. 853 (1989).
Ruggeri et al., Inhibition of Platelet Function With Synthetic Peptides Designed to be High-Affinity Antagonists of Fibrinogen Binding to Platelets; Proc. Natl. Acad. Sci. USA, 83:5708-5712 (1986).
Rucinski et al., Batroxostatin, A RGD Containing Peptide from B. Atrox Venom, is a Potent Inhibitor of Cell Interaction with Adhesive Proteins, Thrombosis and Haemostasis, 62:50, Abstract No. 1560 (1989).
Ruoslahti et al., New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238:491-497 (1987).
Ruoslahti et al., Arg-Gly-Asr: A Versatile Cell Recognition Signal, Cell, 44:517-518 (1986).
Samanen et al., An RGD-Peptide Analog with Potent Antithrombotic Activity In Vivo, J. Cell. Biol. Supplement 14A:A229 (1990).
Shebuski et al., Characterization and Platelet Inhibitory Activity of Bitistatin, a Potent Arginine-Glycine-Aspartic Acid Containing Peptide from the Venon of the Viper Bitis Arietans, J. Biol. Chem., 264:21550-21556 (1989).
Timmons et al., Antiplatelet "Hybrid" Peptide Analagous to Receptor Recognition Domains on .gamma. and a .alpha. Chains of Human Fibrinogen, Biochemistry, 28:2919-2923 (1989).
Tranqui et al., Differential Structural Requirements for Fibrinogen Binding to Platelets and Endothelial Cells, J. Cell Biol., 108:2519-2527 (1989).
Williams et al, Inhibition of von Willebrand Factor Binding to Platelets by Two Recognition Site Peptides: The Pentadecapeptide of The Carboxy Terminus of the Fibrinogen Gamma Chain and the Terapeptide Arg-Gly-asp-Ser, Thrombosis Research, 46:457-471 (1987).
Yasuda et al., Monoclonal Antibody Against the Platelet Glycoprotein (GP) IIb/IIa Recepter Prevents coronary Artery Reocclusion After Reperfusion with Recombinant Tissue-Type Plasminogen Activator in Dogs, J. Clin. Invest. 81: 1284-1291 (1988).
11th American Peptide Symposia, San Diego, California, Jul. 9-14, 1989.
Caron, et al., Synthetic Peptide with Antithrombotic Activity, Peptides, Chemistry, Structure and Biology, Proceedings of the Eleventh American Peptide Symposium, Jul. 9-14, 1989, La Jolla, CA, pp. 82-83.
Ginsberg, et al., Inhibition of Fibronectin Binding to Platelets by Proteolytic Fragments and Synthetic Peptides Which Support Fibroblast Adhesion, The Journal of Biological Chemistry, 260(7):3931-3936 (1985).
Hanson et al., Baboon Models of Acute Arterial Thrombosis, Thrombosis and Haemostatis, 58(3):801-805 (1987).
Hanson et al., Platelet Interactions with Dacron Vascular Grafts, Arteriosclerosis, 5:595-603 (Nov./Dec. 1985).
Huang et al., Mechanism of Action of the Platelet Aggregation Inhibitor Purified from Agkistrodon Halys (Mamushi) Snake Venom, Toxicon, 22:243-252 (1984).
Huang et al., Characterization of a Potent Platelet Aggregation Inhibitor from Agkistrodon Rhosodstoma Snake Venom, Biochimica et Biophysica Acta 22789, 925:248-257 (1987).
Kosugi et al., Isolation of Platelet Aggregation Inhibitor from Trimeresurus Flavoviridis Snake Venom, The Snake, 17:117-123 (1985).
Kumagai, et al., Effect of Cyclic RGD Peptide On Cell Adhesion and Tumor Metastasis, Biochemical and Biophysical Research Communications, 177(1):74-82 (1991).
Musial, et al., Inhibition of Platelet Adhesion to Surfaces of Extracorporeal Circuits by Disintegrins, Circulation, 82(1) :262-273 (1990).
Nutt, et al., Development of Novel, Highly Selective Fibrinogen Receptor Antagonists as Potentially Useful antithrombotic Agents, Peptides, Chemistry and Biology, Proceedings of the Twelfth American Peptide Symposium, Jun. 16-21, 1991, Cambridge, MA, pp. 914-916.
Nutt, et al., Structure- and Conformation-Activity Studies Leading to
COR Therapeutics Inc.
Huff Sheela
LandOfFree
Platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2046361